Статья

The conundrum of human immune system “senescence”

G. Pawelec, A. Bronikowski, S. Cunnane, L. Ferrucci, C. Franceschi, T. Fülöp, P. Gaudreau, V. Gladyshev, E. Gonos, V. Gorbunova, B. Kennedy, A. Larbi, J. Lemaître, G. Liu, A. Maier, J. Morais, O. Nóbrega, A. Moskalev, M. Rikkert, A. Seluanov, A. Senior, S. Ukraintseva, Q. Vanhaelen, J. Witkowski, A. Cohen,
2021

There is a great deal of debate on the question of whether or not we know what ageing is (Ref. Cohen et al., 2020). Here, we consider what we believe to be the especially confused and confusing case of the ageing of the human immune system, commonly referred to as “immunosenescence”. But what exactly is meant by this term? It has been used loosely in the literature, resulting in a certain degree of confusion as to its definition and implications. Here, we argue that only those differences in immune parameters between younger and older adults that are associated in some definitive manner with detrimental health outcomes and/or impaired survival prospects should be classed as indicators of immunosenescence in the strictest sense of the word, and that in humans we know remarkably little about their identity. Such biomarkers of immunosenescence may nonetheless indicate beneficial effects in other contexts, consistent with the notion of antagonistic pleiotropy. Identifying what could be true immunosenescence in this respect requires examining: (1) what appears to correlate with age, though generality across human populations is not yet confirmed; (2) what clearly is part of a suite of canonical changes in the immune system that happen with age; (3) which subset of those changes accelerates rather than slows aging; and (4) all changes, potentially population-specific, that accelerate agig. This remains an immense challenge. These questions acquire an added urgency in the current SARS-CoV-2 pandemic, given the clearly greater susceptibility of older adults to COVID-19. © 2020 Elsevier B.V.

Цитирование

Похожие публикации

Документы

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • G. Pawelec
    Department of Immunology, University of Tübingen, Tübingen, Germany
  • A. Bronikowski
    Health Sciences North Research Institute, Sudbury, ON, Canada
  • S. Cunnane
    Department of Ecology, Evolution, and Organismal Biology, Iowa State University, Ames, IA 50011, United States
  • L. Ferrucci
    Department of Medicine and Research Center on Aging, Université de Sherbrooke, Sherbrooke, Québec, Canada
  • C. Franceschi
    National Institute on Aging, 241 Bay View Boulevard, Baltimore, MD 21225, United States
  • T. Fülöp
    Mater Studiorum University of Bologna, Italy
  • P. Gaudreau
    Laboratory of Systems Biology of Healthy Aging, Department of Applied Mathematics, Lobachevsky State University, Nizhny Novgorod, Russian Federation
  • V. Gladyshev
    Department of Medicine, Geriatric Division, University of Sherbrooke, 3001 12 Ave N, Sherbrooke, QC J1H 5N4, Canada
  • E. Gonos
    Research Center on Aging, 1036 Rue Belvédère S, Sherbrooke, QC J1H 4C4, Canada
  • V. Gorbunova
    Department of Medicine, University of Montreal, Montreal, QC, Canada
  • B. Kennedy
    Centre Hospitalier de l'Université de Montréal Research Centre, Montreal, QC, Canada
  • A. Larbi
    Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, United States
  • J. Lemaître
    National Hellenic Research Foundation, Institute of Chemical Biology, Athens, Greece
  • G. Liu
    Departments of Biology and Medicine, University of Rochester, Rochester, NY 14627, United States
  • A. Maier
    Healthy Longevity Programme, Yong Loo Lin School of Medicine, National University of Singapore, 10 Medical Dr.117597, Singapore
  • J. Morais
    Centre for Healthy Longevity, National University Health System, 1E Kent Ridge Rd., Singapore, 119228, Singapore
  • O. Nóbrega
    Singapore Institute of Clinical Sciences, A⁎STAR, Singapore, 117609, Singapore
  • A. Moskalev
    Buck Institute for Research on Aging, 8001 Redwood Blvd., Novato, CA 94945, United States
  • M. Rikkert
    A⁎STAR, 8 Biomedical Grove, #07, Neuros, Singapore, 138665, Singapore
  • A. Seluanov
    Université de Lyon, Lyon, F-69000, France
  • A. Senior
    Université Lyon 1, CNRS, UMR5558, Laboratoire de Biométrie et Biologie Évolutive, Villeurbanne, F-69622, France
  • S. Ukraintseva
    State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China
  • Q. Vanhaelen
    Department of Medicine and Aged Care, @AgeMelbourne, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia
  • J. Witkowski
    Department of Human Movement Sciences, @AgeAmsterdam, Faculty of Behavioral and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam Movement Sciences, Amsterdam, Netherlands
  • A. Cohen
    Division of Geriatric Medicine, Faculty of Medicine, McGill University and Research Institute of the McGill University Health Centre, Montreal, QC, Canada
Название журнала
  • Mechanisms of Ageing and Development
Том
  • 192
Страницы
  • -
Ключевые слова
  • aging; anthropometry; Article; autoimmune disease; CD4+ T lymphocyte; CD8+ T lymphocyte; frailty; human; immune system; immunosenescence; infection; malignant neoplasm; morbidity; mortality; nonhuman; outcome assessment; priority journal; sarcopenia; survival; vaccination; adult; aged; epidemiology; immunology; middle aged; pandemic; pathology; therapy; biological marker; Adult; Aged; Biomarkers; COVID-19; Humans; Immunosenescence; Middle Aged; Pandemics; SARS-CoV-2
Издатель
  • Elsevier Ireland Ltd
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus